Treeline Biosciences is a privately held, clinical-stage biopharma company building transformative precision medicines for patients with hard-to-treat conditions including cancer, autoimmune and neurological diseases. They aspire to make medicines at the highest level.
- Category
- Precision Medicine
- Stage
- Series A
- Employees
- 162
- HQ
- Watertown, United States
- Founded
- 2021
- Funding
- $1.1B